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Self-targeting, zwitterionic micellar dispersants 
enhance antibiotic killing of infectious biofilms—An 
intravital imaging study in mice
Shuang Tian1,2, Linzhu Su1,2, Yong Liu1,2*, Jingjing Cao1, Guang Yang1,2, Yijin Ren3, Fan Huang4, 
Jianfeng Liu4†, Yingli An1, Henny C. van der Mei2†, Henk J. Busscher2†, Linqi Shi1† 
Extracellular polymeric substances (EPS) hold infectious biofilms together and limit antimicrobial penetration 
and clinical infection control. Here, we present zwitterionic micelles as a previously unexplored, synthetic 
self-targeting dispersant. First, a pH-responsive poly(-caprolactone)-block-poly(quaternary-amino-ester) was 
synthesized and self-assembled with poly(ethylene glycol)-block-poly(-caprolactone) to form zwitterionic, mixed-
shell polymeric micelles (ZW-MSPMs). In the acidic environment of staphylococcal biofilms, ZW-MSPMs became 
positively charged because of conversion of the zwitterionic poly(quaternary-amino-ester) to a cationic lactone 
ring. This allowed ZW-MSPMs to self-target, penetrate, and accumulate in staphylococcal biofilms in vitro. In vivo 
biofilm targeting by ZW-MSPMs was confirmed for staphylococcal biofilms grown underneath an implanted 
abdominal imaging window through direct imaging in living mice. ZW-MSPMs interacted strongly with important 
EPS components such as eDNA and protein to disperse biofilm and enhance ciprofloxacin efficacy toward remaining 
biofilm, both in vitro and in vivo. Zwitterionic micellar dispersants may aid infection control and enhance efficacy 
of existing antibiotics against remaining biofilm.
INTRODUCTION
Infectious bacterial biofilms are difficult to penetrate by antimicrobials 
(1, 2). Combined with the increase in antibiotic resistance in many 
pathogens, this forms a growing threat to public health, which has 
been predicted to cause antimicrobial-resistant infections to become 
the number one cause of human death within three decades (3). 
Unfortunately, at the same time, the incentives for development and 
marketing of new antibiotics are relatively low because the effective 
lifetime of new antibiotics from their first clinical use until the ap-
pearance of the first resistant bacterial strains is becoming shorter 
and shorter (4). This hampers return of investment of industrial en-
deavors needed for successful clinical translation (5). Accordingly, 
new strategies to complement current antibiotic treatment by exist-
ing antibiotics or even to fully replace antibiotics are direly needed 
to prevent this frightening scenario from becoming reality (6–8).
Biofilms are held together by a matrix composed of extracellular 
polymeric substances (EPS) (9, 10). The EPS matrix is self-produced 
by bacteria inhabiting a biofilm and constitutes a protective barrier 
toward penetration of antimicrobials and host immune cells (11–15). 
Despite the importance of the EPS matrix for protecting biofilm 
inhabitants and biofilm cohesivity, dispersal of biofilm inhabitants 
to escape a biofilm, e.g., during times of overpopulation and nutrient 
scarcity, is an essential part of the biofilm life cycle (16–19). Disper-
sal of infectious biofilms in a human host may cause spreading of 
infectious bacteria within the host but is more and more regarded 
as a new therapeutic strategy to replace or complement antibiotic 
treatment because, once dispersed in the blood circulation, plank-
tonic bacteria in suspension are more susceptible to host immune 
cells than bacteria in a biofilm mode of growth. Moreover, once 
suspended in the blood circulation, infectious bacteria are many-
fold more susceptible to antibiotics than in a biofilm mode of 
growth (16, 20–24).
The major components in the EPS matrix responsible for 
keeping a biofilm together are extracellular DNA (eDNA), poly-
saccharides, and glycoproteins that function as a glue interacting 
with biofilm bacteria (15, 25, 26). A variety of bacterially produced 
enzymes and biosurfactants such as deoxyribonuclease (20, 27–30), 
dispersin B (16, 31, 32), and rhamnolipids (33–35) have been de-
scribed to be responsible for natural biofilm dispersal and are also 
regarded for potential therapeutic use. However, bacterial enzymes 
and biosurfactants mostly interact with a single EPS component 
and are difficult to isolate, while their stability is often low. These 
aspects yield a need for the development of cost-effective and stable 
synthetic dispersants, interacting with all three major EPS compo-
nents to facilitate broad clinical use.
Cationic nanoparticles are often unable to penetrate into a bio-
film but accumulate at its surface (36), while anionic and neutral 
nanoparticles neither penetrate in nor adsorb to the biofilm and 
are easily rinsed out (37). Although cationic micelles can disrupt 
biofilms (38, 39), they lack the ability to self-target biofilm in-
habitants. Mixed-shell polymeric micelles (MSPMs) composed of a 
poly(ethylene glycol) (PEG) shell and a pH-responsive poly(-amino 
ester) have previously been demonstrated to perform very well 
in vitro and in vivo as antimicrobial nanocarriers, which could be 
transported through the blood owing to their stealth properties 
(40, 41). Their pH responsiveness allowed them to self-target to 
negatively charged bacteria in the acidic environment of in vitro 
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biofilms, as microscopically imaged using fluorescent micelles. 
However, in vivo targeting has only been indirectly inferred and 
never been directly imaged because of lack of experimental possi-
bilities. After biofilm targeting, release of their antimicrobial cargo 
was stimulated by the lipase activity of biofilm bacteria, with, as a 
final result, the killing of biofilm inhabitants. We here demonstrate 
a totally new type of micelle, combining self-targeting and the ability 
to disrupt biofilm in one micelle. These dual-function micelles 
were self-assembled from PEG-block-poly(-caprolactone) (PEG-
b-PCL) and PCL-block-poly(quaternary amino ester) (PCL-b-PQAE) 
and equipped with a zwitterionic (ZW), pH-responsive derivative 
of carboxybetaine having hydroxyl groups. The ZW group acted as 
a synthetic micellar dispersant of biofilm, interacting with eDNA 
and protein as the most important EPS components to interfere with 
their function as a glue holding biofilm bacteria together. Self- 
targeting was not only demonstrated in vitro but, uniquely, also 
directly imaged in vivo using intravital imaging (42) in living mice. 
To our knowledge, the use of intravital imaging in infectious bio-
film research is new. Throughout this work, PEG-b-PCL single-shell 
polymeric micelles (SSPMs) were used for comparison to create a more 
or less comparable chemistry without the ZW feature. Use of a non– 
pH-sensitive zwitterion would have yielded a different chemistry.
RESULTS
Synthesis and characterization of ZW-MSPMs
An amphiphilic block copolymer PEG-b-PCL (43) (fig. S1A) was 
synthesized, as described before [see fig. S1B for 1H nuclear magnetic 
resonance (NMR) spectrum], while a newly designed pH-responsive 
copolymer PCL-b-PQAE was synthesized, as schematically pre-
sented in fig. S2A. Successful synthesis of PCL-b-PQAE was 
demonstrated in the 1H NMR spectra presented in fig. S3 (A and B). 
Synthesis of PCL-b-PQAE had a yield of 73%. Note, from the 1H 
NMR spectrum in fig. S3B, that all of the bromoacetic acid was sub-
stituted. ZW PQAE changed to a lactone ring structure in trifluoro-
acetic acid to exhibit positive charge (fig. S2B). This conversion was 
monitored by 1H NMR as a function of time (see Fig. 1A), reaching 
a conversion of 90% within 40 min under acidic conditions. PEG-
b-PCL was synthesized to fabricate SSPMs for comparison. SSPMs 
and ZW-MSPMs were obtained by self-assembly in aqueous solu-
tion of PEG-b-PCL in the absence or presence of PCL-b-PQAE, 
respectively. Critical micelle concentrations (CMCs) (fig. S4) of 
SSPMs were slightly smaller (1.24 g ml−1) than that of ZW-MSPMs 
(1.52 g ml−1). ZW-MSPMs and SSPMs had comparable diameters 
of around 80 nm (Fig. 1, B and C). Micellar diameters were inde-
pendent of pH over the pH range 5.0 to 7.4. At pH 5.0, SSPMs had 
a negative zeta potential of around −5 mV that remained constant 
in time, while ZW-MSPMs demonstrated an increase in zeta poten-
tial from −10 mV to around +12 mV after 90 to 120 min (Fig. 1D). 
This time dependence confirmed that the formation of a positively 
charged lactone ring structure is a relatively slow process, in line 
with the conclusion drawn from 1H NMR. SSPM zeta potentials re-
mained negative over the pH range 5.0 to 7.4, but the zeta potential 
of ZW-MSPMs became more positive upon pH decrease (Fig. 1E).
Self-targeting and antibacterial activity of  
ZW-MSPMs in vitro
In vitro, the pH responsiveness of the ZW-MSPMs allowed them to 
self-target up to 78% of planktonic Staphylococcus aureus in sus-
pension under acidic (pH 5.0) conditions, as existing in a biofilm 
(9). Oppositely, ZW-MSPMs at pH 7.4 self-targeted less than 11% 
of S. aureus in suspension, similar to SSPMs in pH 7.4 and 5.0 (fig. 
S5). Exposure of planktonic staphylococci to either ZW-MSPM or 
SSPM suspensions did not affect bacterial growth (fig. S6). The in-
ability of MSPMs to self-target negatively charged bacteria at pH 7.4 
in vitro has been amply demonstrated (40). Lack of in vitro self- 
targeting at physiological pH is confirmed here by the lack of pene-
tration and accumulation of Nile red–loaded ZW-MSPMs over 
the height of an S. aureus biofilm at pH 7.4 versus good penetration 
and accumulation at pH 5.0 after short exposure times of only 30 min 
(Fig. 2, A and B). The distribution of green and red fluorescent pixels 
as a function of height at pH 5.0 overlaps (Fig. 2C), attesting the 
in vitro self-targeting of ZW-MSPMs to staphylococci, also in a 
biofilm mode of growth.
Intravital imaging in mice to demonstrate self-targeting 
of ZW-MSPMs in vivo
Self-targeting of smart nanocarriers has never been directly imaged 
in vivo but only indirectly inferred on the basis of a combination of 
in vitro and in vivo data. To directly confirm biofilm self-targeting 
by ZW-MSPMs in vivo, green fluorescent staphylococcal biofilms 
were grown underneath abdominal imaging windows (AIWs) in 
living mice (Fig. 2D) (42). An AIW uniquely allows for real-time 
observation of fluorescent biofilm and its targeting by fluorescent, 
smart nanocarriers, using a two-photon laser scanning confocal 
microscope. To this end, anesthetized mice were placed on the mi-
croscope stage by fixing the abdominal window frame in a clamp 
for intravital imaging (Fig. 2E). First, staphylococci were injected 
underneath the window [2 × 108 colony-forming units (CFUs) per 
site] to grow a biofilm for 48  hours. After 48  hours of in  vivo 
growth, staphylococcal biofilm were found, using intravital imaging, 
to be around 70 m thick (Fig. 2, F and G). This thickness is com-
parable with human clinical biofilms (44). Self-targeting of 
ZW-MSPMs in vivo was demonstrated by injection of red fluorescent 
Nile red–loaded SSPMs or ZW-MSPMs suspended in phosphate- 
buffered saline (PBS) into the tails of the mice. Subsequently, mice 
were held fixed on the microscope stage, and micellar targeting to 
the staphylococcal biofilm was real-time imaged as a function of 
time after injection of the micelle suspensions. SSPMs did not 
self-target to the biofilm (Fig. 2F), but real-time imaging demon-
strated arrival of the first Nile red–loaded ZW-MSPMs in the bio-
films after 20 min of blood circulation (Fig. 2G and movie S1), after 
which, penetration and accumulation of ZW-MSPMs in the bio-
films continued (Fig. 2H). In mice without a biofilm grown under-
neath the intravital window, intensity of red fluorescence underneath 
the window was below detection (Fig. 2, F and G) after tail injec-
tion of Nile red–loaded SSPMs or ZW-MSPMs (Fig. 2, F and G).
Dispersal of biofilms by ZW-MSPMs
Next, to study dispersal of S. aureus biofilms by ZW-MSPMs, biofilms 
were exposed in vitro to PBS [10 mM potassium phosphate and 150 
mM NaCl (pH 5.0)] and SSPMs or ZW-MSPMs suspended at dif-
ferent concentrations in PBS for 120 min and stained with crystal violet 
(CV). Loss of CV-stainable biofilm mass upon exposure to ZW-MSPM 
suspensions increased with increasing micelle concentration, while 
exposure to PBS (0 g ml−1) or SSPM suspensions yielded no loss of 
biomass, regardless of micelle concentration (Fig. 3A). Dispersal 
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biofilms to PBS, suspended SSPMs, or ZW-MSPMs (no Nile 
red loading) and subsequent staining with red fluorescent conca-
navalin A to visualize bacteria and their EPS matrix (Fig. 3B). 
COMSTAT analysis (45) demonstrated that before exposure, in vi-
tro staphylococcal biofilms had a thickness of 20.0 ± 1.6 m 
(Fig. 3C). Exposure to PBS or SSPM suspensions did not affect bio-
film thickness and it remained at 20.0 ± 0.8 m. However, upon expo-
sure to ZW-MSPM suspensions, staphylococcal biofilm thickness 
significantly decreased to 10.0 ± 1.4 m, confirming the results ob-
tained after CV staining of exposed biofilms [compare Fig. 3 (A 
and C)]. COMSTAT was also used to derive the biomass distribu-
tion over the height of a biofilm distinguishing bacteria and EPS. 
Exposure to PBS yielded a similar distribution of bacterial mass 
and EPS, as did exposure to an SSPM suspension (Fig. 3D). ZW-
MSPM suspensions, on the other hand, caused a major loss of EPS 
over the height of remaining biofilm that was smaller than the cor-
responding heights after exposure to PBS or SSPM suspensions (see 
also Fig. 3D). COMSTAT analysis of biomass, separated in bacterial 
mass and EPS of the entire thickness of exposed biofilm, confirmed 
significant loss of bacterial mass and EPS upon exposure of 
staphylococcal biofilms to ZW-MSPM suspensions (Fig. 3E).
Interaction of ZW-MSPMs with biofilm matrix components
To find out which of the major EPS components in S. aureus bio-
films interacted with ZW-MSPMs, the interaction of herring sperm 
DNA [as an eDNA mimic in the EPS matrix (46, 47)] and amyloid 
Fig. 1. Characterization of ZW-MSPMs and SSPMs prepared. (A) 1H NMR spectra of the PQAE conversion in trifluoroacetic acid. The peak shift from A [3.92 parts per 
million (ppm)] to B (4.54 ppm) indicates the conversion of the ZW structure to a lactone ring structure. (B) Hydrodynamic diameter distributions of SSPMs and ZW-MSPMs 
at pH 7.4 in phosphate-buffered saline (PBS; 10 mM potassium phosphate and 150 mM NaCl). (C) Transmission electron microscopy (TEM) micrographs of SSPMs and 
ZW-MSPMs at pH 7.4. (D) Zeta potentials of ZW-MSPMs and SSPMs in PBS as a function of time measured at pH 5.0 (37°C). (E) Zeta potentials of ZW-MSPMs and SSPMs as 
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fibrils [endogenous to S. aureus biofilms (48–50)] with ZW-
MSPMs was investigated using different in vitro methods. In an 
acidic environment, positively charged ZW-MSPMs in PBS (pH 5.0) 
interacted significantly better with DNA (Fig. 4A) and protein-
aceous amyloidal fibrils (Fig. 4B) than SSPMs. EPS remained clearly 
visible in biofilms after exposure to PBS or SSPM suspensions 
(Fig. 4C). After exposure to ZW-MSPM suspensions, all traces of 
the EPS matrix components were removed from the remaining 
staphylococcal cell surfaces (Fig. 4C). This points to a stronger inter-
action between ZW-MSPMs with staphylococci than between EPS 
matrix components and staphylococci. Thus, interactions between 
ZW-MSPMs and staphylococci will impede or break interactions 
between matrix components and bacterial inhabitants within a biofilm 
and, therewith, negatively affect biofilm integrity to yield dispersal.
One of the main causes of biofilm resistance to antibiotics is that 
the EPS matrix prevents the penetration of antibiotics. ZW-MSPMs 
Fig. 2. Self-targeting in S. aureus ATCC12600GFP biofilms of Nile red–loaded ZW-MSPMs in vitro and in vivo. (A) In vitro self-targeting of Nile red–loaded ZW-MSPMs 
into green fluorescent, 48-hour-old biofilms after 30 min of exposure to Nile red–loaded ZW-MSPMs suspended in PBS. (B) In vitro accumulation of Nile red–loaded ZW-
MSPMs as a function of biofilm height. Accumulation was normalized with respect to the maximum intensity (pH 5.0). (C) Normalized green and red fluorescence as a 
function of biofilm height after in vitro accumulation of ZW-MSPMs at pH 5.0. Overlap of both curves indicates targeting of ZW-MSPMs to staphylococci. (D) A mouse with 
an abdominal imaging window (AIW) implanted in its flank underneath in which a green fluorescent staphylococcal biofilm was grown. (E) Custom-designed microscope 
stage, with the window frame fixed in a clamp to ensure proper intravital focusing over time. (F) Reconstructed three-dimensional (3D) intravital images of green fluores-
cent, 48-hour-old staphylococcal biofilms grown underneath the AIW, taken 30 min after injection of a Nile red–loaded SSPM suspension in PBS (pH 7.4). The bottom 
intravital image is the red fluorescence channel, taken 30 min after injection of a Nile red–loaded SSPMs suspension in mice without a staphylococcal biofilm grown under-
neath the window. (G) Same as (F), demonstrating in vivo accumulation of red fluorescent ZW-MSPMs in the 48-hour-old biofilm. (H) Red fluorescence intensity due to 
Nile red–loaded ZW-MSPMs accumulated in a 48-hour-old biofilm underneath the window as a function of time after tail injection of micelles. Intravital images were 
taken every 2 min. In three mice, without a biofilm grown underneath the window, no detectable red fluorescence due to micelle accumulation was observed. Red fluo-
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were shown here to disperse a staphylococcal biofilm, although 
roughly half of a staphylococcal biofilm was remaining (Fig. 3, 
C and E). However, because of reduced presence of EPS-induced 
coherence of the biofilm (Fig. 4C), the remaining biofilm after 
exposure to ZW-MSPM suspensions was easier to penetrate by ci-
profloxacin, a common antibiotic in the clinical treatment of 
staphylococcal infections (Fig. 5, A and B), than when exposed to 
PBS or SSPM suspensions. Moreover, whereas the biofilm thickness 
(Fig. 3C) and biomass (Fig. 3E) were reduced twofold upon exposure 
to ZW-MSPM suspensions compared to PBS and SSPM suspensions, 
staphylococcal killing increased four log units of CFUs (Fig. 5, 
C and D). Thus, it can be concluded that pre-exposure of biofilms 
to ZW-MSPM suspensions enhanced bacterial killing by antibiot-
ics, with a clear impact of antibiotic concentration (see also Fig. 5C).
Effect of biofilm dispersal by ZW-MSPMs on antibiotic 
efficacy in vivo
In a second series of in vivo experiments, an infectious biofilm 
grown underneath an AIW was imaged during consecutive injec-
tion of micelles and ciprofloxacin. Ciprofloxacin was injected in 
the tails of the mice, immediately after tail injection of PBS, SSPMs 
or ZW-MSPMs suspended in PBS at pH 7.4 (see scheme in Fig. 6A). 
Fig. 3. Dispersal of 48-hour-old S. aureus ATCC12600GFP biofilms upon 120 min of exposure to ZW-MSPMs or SSPMs in PBS (pH 5.0). (A) CV-stainable bacterial 
biomass relative to PBS (pH 5.0), derived from optical density at 595 nm (OD595nm) after CV staining of in vitro–grown S. aureus biofilms as a function of micelle concentra-
tion in suspension. (B) Confocal laser scanning microscopy (CLSM) micrographs of staphylococcal biofilms exposed to PBS or suspensions (200 g ml−1) of SSPMs and 
ZW-MSPMs. (C) Thickness of staphylococcal biofilms after exposure to PBS or suspensions of SSPMs or ZW-MSPMs. (D) Example of biomass distribution after exposure to 
PBS, or suspensions (200 g ml−1) of SSPMs and ZW-MSPMs, across the height of the staphylococcal biofilms. Bacterial biomass was derived from green fluorescent pixels, 
while EPS mass was derived from red fluorescent pixels. Maximal green and red fluorescence intensities after exposure were set to 100%. (E) Biomass relative to PBS of 
bacteria and EPS, derived from COMSTAT analysis of CLSM images of staphylococcal biofilms exposed to micellar suspensions [micelles (200 g ml−1)]. All error bars de-
note SDs over three experiments with separately prepared micelle batches and differently grown staphylococcal cultures. ** denotes statistically significant differences 










Tian et al., Sci. Adv. 2020; 6 : eabb1112     14 August 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 13
The green fluorescent staphylococcal biofilm remained clearly ob-
servable upon pretreatment with tail injection of PBS or an SSPM 
suspension followed by ciprofloxacin injection for at least 5 days. 
However, when a ZW-MSPM suspension was applied in combina-
tion with subsequent ciprofloxacin injection, the infectious bio-
film entirely disappeared over the course of 3 to 5 days (Fig. 6B). 
Biofilm thickness and biomass decreased as a function of time after 
injection [Fig. 6 (C and D, respectively)], most notably after tail 
injection of a ZW-MSPM suspension and ciprofloxacin. After 
sacrifice, the surrounding tissue excised from the infection site 
harvested a four log unit–larger reduction in CFUs (CFUs/site) 
after pretreatment with a ZW-MSPM suspension followed by 
ciprofloxacin than when PBS or a SSPM suspension was applied as 
a pretreatment (Fig. 6E). Eradication of the infectious staphylococci 
at sacrifice due to pretreatment with a ZW-MSPM suspension fol-
lowed by ciprofloxacin injection was confirmed by enumeration of 
white blood cells and neutrophilic granulocytes in blood after sac-
rifice, a key parameter to indicate the status of bacterial infection 
(51, 52). Five days after pretreatment with a ZW-MSPM suspen-
sion and ciprofloxacin injection, white blood cell counts were back 
to normal and granulocyte counts were almost back to normal, 
while highly elevated immune cell counts were still found in the 
blood of mice pretreated with PBS or a SSPM suspension (fig. S7). 
Concentrations of other blood markers were all within the range 
observed for uninfected mice (fig. S8), indicating the absence of 
adverse blood reactions, for both SSPM and ZW-MSPM suspen-
sions. No indications were found of micelle collection in or damage 
to the major organs, as can be concluded from histological images 
of the heart, liver, spleen, lung, and kidney (fig. S9).
DISCUSSION
In conclusion, this work describes the synthesis of new self-targeting 
ZW-MSPMs as a synthetic biofilm dispersant. Use as a dispersant 
is an entirely new application of MSPMs. When equipped with ZW 
and pH-responsive PQAE and PEG, ZW-MSPMs had the ability to 
interact strongly with major components (eDNA and protein) of the 
EPS matrix of staphylococcal biofilms to disrupt the interaction 
between bacterial inhabitants with the EPS matrix and, therewith, 
the cohesivity of the biofilm, yielding its dispersal. Uniquely, 
micellar self-targeting toward an infectious biofilm was observed 
real time in living mice underneath an AIW implanted in their 
flanks, providing the first direct evidence of self-targeting through 
the blood circulation of tail-injected ZW-MSPMs toward an infec-
tious biofilm in mice (Fig. 2, F and G). None of other self-targeting, 
pH-responsive nanocarriers described in the literature (24–30) have 
yet been directly demonstrated to be able to find their own highway 
through the body of a living animal toward an infection site. This 
shows the great potential of intravital imaging for demonstration 
of proof of principle. In line with the recommendations of an inter-
national consortium (53), suggesting to solely conduct animal 
experiments for preclinical proof of principle and safety, we relied 
on in vitro models to explore mechanisms of action of our ZW-
MSPMs. In addition, although the morbidity of placing an AIW is 
unexpectedly low, possibly comparable with the inconvenience en-
countered by patients with intestinal stoma, we limited animal use 
to three animals per group, as also suggested by the international 
consortium (53).
Pretreatment of an existing staphylococcal biofilm with ZW-MSPM 
suspensions made the remaining biofilm more susceptible to 
Fig. 4. Interactions of SSPMs or ZW-MSPMs suspended in PBS (pH 5.0) with two major staphylococcal EPS components and effects on a 48-hour-old biofilm 
(scanning electron microscopy). (A) Effects of exposure of DNA for 120 min to PBS or suspensions (200 g ml−1) of SSPMs or ZW-MSPMs. DNA interaction was assessed 
by an ethidium bromide (EB) displacement assay, with 100% coinciding with full displacement of EB. (B) Same as (A), for interaction with proteinaceous amyloidal fibrils. 
Amyloid interaction was assessed by a thioflavin T (ThT) fluorescence assay, with 100% coinciding with full disruption of amyloid fibrils. Error bars denote SDs over three 
experiments with separately prepared micelle batches. *** and **** indicate statistically significant differences at P < 0.001 and P < 0.0001, respectively (Student’s t test). 
(C) Scanning electron microscopy (SEM) images of 48-hour-old S. aureus ATCC12600GFP biofilms after 120 min of exposure to PBS or suspensions (200 g ml−1) of SSPMs 
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ciprofloxacin penetration and killing of its inhabitants than pre-
treatment with PBS or SSPM suspensions, both in vitro and in vivo. 
Staphylococcal biofilms grown in mice underneath an AIW fully 
disappeared within 5 days after pretreatment with a ZW-MSPM sus-
pension followed by ciprofloxacin injection, while undispersed bio-
film remained clearly observable when SSPMs were applied (Fig. 6). 
Although, a priori, there are no reasons to assume that the ZW 
micellar dispersants prepared will not work on biofilms grown from 
other infectious bacterial strains and species, we have also deter-
mined the interaction of the ZW-MSPMs with alginate, an important 
EPS component in Gram-negative pseudomonas biofilms. ZW-MSPMs 
also demonstrated a strong interaction with alginate (fig. S10). 
Thus, it can be expected that our dual-function ZW-MSPMs will 
show disperse infectious biofilms of other pathogens, but this 
remains to be confirmed. Similarly, although within reason to 
expect, enhanced antibiotic efficacy in combination with our 
micellar dispersants should also be confirmed for other antibiotics.
In mice, no adverse effects were observed of the dual-function 
ZW-MSPMs, paving the way to clinical application. With respect 
to clinical application of our micellar dispersants, synthetic 
ZW micellar dispersants are cheap and easy to manufacture. 
ZW-MSPMs in combination with existing antibiotics aid infection 
control by enhancing the efficacy of antibiotic treatment. However, 
they may also aid infection control without their combination with 
existing antibiotics. This is because dispersed bacteria are more 
easily cleared from the blood circulation by immune cells 
than bacteria in a biofilm mode of growth (16). However, before 
possible stand-alone use, it may be considered advantageous that 
clinical trials can be carried out by combining existing antibiotics 
with our synthetic ZW dispersants. In a first instance, this might 
be done for easy-to-treat infections and slowly progressing to 
more serious hard-to-treat antibiotic-resistant infections. Such a 
step-by-step approach likely will be more acceptable for clinical 
trials than an approach in which a seriously infected patient is from 
the onset made 100% dependent on a novel therapy.
MATERIALS AND METHODS
Materials
Monomethoxy PEG (CH3O-PEG-OH; Mw = 2000) was purchased 
from Fluka (Shanghai, China) and dried under vacuum before use. 
-Caprolactone (-CL; 99% purity), purchased from Alfa Aesar 
(Shanghai, China), was dried with calcium hydride and was sub-
sequently distilled under vacuum conditions. Stannous octoate 
[Sn(Oct)2; 95% purity] was purchased from J&K (Beijing, China) 
and used as received. All other materials and solvents were used as 
Fig. 5. Antibiotic effects on 48-hour-old S. aureus ATCC12600GFP biofilm remaining after dispersal by exposure to ZW-MSPMs or SSPMs suspended in PBS 
(pH 5.0). (A) CLSM images of the penetration of red fluorescent ciprofloxacin (CIP) in in vitro–grown S. aureus biofilms after 120 min of exposure to PBS or suspensions 
(200 g ml−1) of SSPMs or ZW-MSPMs. (B) Red fluorescence due to ciprofloxacin penetration, as a function of height in staphylococcal biofilms, derived from CLSM images 
(A). (C) Viability of staphylococci in a biofilm mode after pre-exposure to TSB or suspensions (200 g ml−1) of SSPMs and ZW-MSPMs for 120 min and subsequent exposure 
to various concentrations of ciprofloxacin in TSB for 5 hours. Staphylococcal viability was assessed from the green fluorescence of the biofilms. Green fluorescence of 
biofilms before ciprofloxacin exposure was set to 100%. (D) Number of S. aureus colonies formed per square centimeter well surface in a biofilm mode, pre-exposed to 
tryptone soya broth (TSB) or suspensions (200 g ml−1) of SSPMs and ZW-MSPMs for 120 min and subsequently exposed to ciprofloxacin (40 g ml−1) for 5 hours. Error bars 
denote SDs over three experiments with separately prepared micelle batches and differently grown staphylococcal cultures. **** indicates statistically significant differ-
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received without further purification from commercial suppliers, 
with the exception of chloroform (CHCl3), which was dried over 
calcium hydride and distilled before use. All aqueous solutions were 
prepared with ultrapure water (resistance, >18 megohm cm−1) 
from a Millipore Milli-Q system.
Synthesis of block copolymers
PEG-b-PCL was synthesized as shown in fig. S1A, as previously 
described (43). 1H NMR identified the polymer prepared as 
PEG45-b-PCL42 (fig. S1B). The number-average molecular weight 
(Mn) and the polydispersity index (Mw/Mn, in which Mw is the 
weight-average molecular weight) of PEG-b-PCL amounted to 
7930 and 1.28, respectively, as determined by gel permeation 
chromatography at 35°C on a Waters 1525 chromatograph equipped 
with a Waters 2414 refractive index detector. Tetrahydrofuran was 
used as eluent at a flow rate of 1 ml min−1. Polystyrene standards 
were used for calibration.
PCL-b-PQAE was synthesized by a Michael-type addition 
polymerization of PCL monoacrylate, hexane-1,6-dioldiacrylate 
(HDD), and ethanolamine (fig. S2A). To obtain PCL monoacrylate, 
Fig. 6. In vivo efficacy of antibiotic treatment of an infectious S. aureus ATCC12600GFP, pretreated with ZW-MSPMs or SSPMs. (A) Experimental scheme for exper-
iments using intravital imaging in mice equipped with an AIW. Consecutive tail injections of micelles and ciprofloxacin were performed daily, starting at day 0, i.e., 
48 hours after initiating growth of an infectious biofilm (day −2). Injection with PBS, SSPMs, or ZW-MSPMs was immediately followed by injection of ciprofloxacin. 
(B) Reconstructed 3D intravital images of green fluorescent S. aureus biofilms before treatment at day 0 and after tail injection of PBS or SSPMs and ZW-MSPMs suspended 
in PBS (pH 7.4; 200 g ml−1), immediately followed by ciprofloxacin in PBS (1 mg ml−1). Images were taken at different days up to sacrifice at day 5. (C) Thickness of staph-
ylococcal biofilms underneath the AIW as a function of time after initiating treatment, derived from COMSTAT analysis of intravital images. (D) Same as (C), now for bio-
mass. (E) Number of S. aureus CFUs obtained from the AIW and infection site tissue excised after sacrifice at day 5. Error bars denote SDs over three mice. **** indicates 
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2-hydroxyethyl acrylate (0.093 g, 0.8 mmol) and -CL (5.0 g, 
43.8 mmol) was dissolved in 15 ml of toluene, after which one drop 
of Sn(Oct)2 was added into the solution. After three freeze-degas-thaw 
cycles, the reaction mixture was stirred at 110°C for 12 hours. Next, 
the solvent was precipitated into excess diethyl ether to obtain the 
crude product. The PCL monoacrylate was dried under vacuum. 
1H NMR identified the degree of polymerization of the PCL mono-
acrylate prepared as 44 (fig. S3A). PCL monoacrylate (2.5 g, 0.5 mmol), 
HDD (3.959 g, 17.5 mmol), and ethanolamine (1.099 g, 18 mmol) 
were carefully weighed and dissolved into 15 ml of anhydrous 
CHCl3 in a round-bottom flask. Polymerization was performed at 
55°C under a dry argon atmosphere for 72 hours. Subsequently, 
excess bromoacetic acid (3.75 g, 27 mmol) was added into the mixed 
solution and stirred for 24 hours to yield PCL-b-PQAE. Then, the 
mixture was precipitated with an excess of cold diethyl ether. The 
precipitate was dried under vacuum, and a pale-yellow solid product 
was obtained with a yield of 73%. 1H NMR identified the polymer 
prepared as PCL44-b-PQAE20 (fig. S3B). Mn was 11,500, while the 
polydispersity index Mw/Mn was 1.33.
Micelle preparation and characterization
Micelles were prepared through nanoprecipitation. Briefly, PEG-b-
PCL and PCL-b-PQAE were dissolved in dimethyl sulfoxide as 
stock polymer solution with a concentration of 5 mg ml−1. For the 
preparation of ZW-MSPMs, 1 ml in PEG-b-PCL stock solution was 
mixed with 1 ml of PCL-b-PQAE stock solution, with an equal 
weight ratio of PEG-b-PCL and PCL-b-PQAE (1:1). The resulting 
solution was added dropwise to 6 ml of deionized water at 30-s 
intervals under vigorous stirring with a magnetic bar. After stirring 
for 2 hours, the micelle solution was transferred to a dialysis bag 
(molecular weight cutoff, 3500) and dialyzed against PBS [10 mM 
potassium phosphate and 150 mM NaCl (pH 7.4)] for 2 days, fol-
lowed by ultrafiltration to remove all precipitation. The SSPMs 
composed of only PEG-b-PCL (SSPMs) were prepared essentially 
the same as the preparation of ZW-MSPMs, the only difference be-
ing that PEG-b-PCL in dimethyl sulfoxide was used.
Dynamic light scattering to determine the micelle diameters 
was done at a 90° scattering angle at 37°C with a 636-nm laser light 
scattering spectrometer (BI-200SM), equipped with a digital cor-
relator (BI-10000AT). Zeta potentials of the micelles were measured 
in PBS at pH 5.0 as a function of time and as a function of pH 
(5.0 to 7.4) after 120-min exposure to each pH using a Brookhaven 
ZetaPALS (Brookhaven Instrument, USA). The instrument uses 
phase analysis scattered light at 37°C to provide an average zeta 
potential over multiple particles. Zeta potentials were measured in 
triplicate with separate batches of micelles. Micelle morphology 
was observed using transmission electron microscopy (TEM; Talos 
F200C, FEI, USA) at an acceleration voltage of 200 kV. Samples 
were prepared for TEM by dropping a micelle suspension onto a 
carbon-coated copper grid and slow drying in vacuo at room 
temperature.
To determine the CMC of SSPMs and ZW-MSPMs, pyrene was 
used as a fluorescence probe. The fluorescence intensity ratio 
between the first vibration peak at 373  nm and the third one at 
384 nm (I373/I384) in the fluorescence emission spectrum of pyrene 
strongly depends on the polarity of the environment to which it is 
exposed. Accordingly, the CMC of a suspension can be determined 
by the change in fluorescence intensity ratio after dissolving pyrene 
in a micelle suspension (54). To this end, pyrene was dissolved in 
acetone at a concentration of 0.6 mM. Ten-microliter aliquots of 
the pyrene solution were added into 1.5-ml Eppendorf centrifuge 
tubes, and the acetone was allowed to evaporate overnight. Next, 
450 l of micelle suspensions diluted in deionized water to different 
concentrations were added into the centrifuge tubes. The tubes were 
shaken overnight on a dry bath incubator in the dark. Fluorescence 
emission spectra were recorded using a fluorescence spectrometer 
(Hitachi F-4600, Tokyo, Japan) at an excitation wavelength of 
334 nm. The emission spectrum was monitored for wavelengths 
between 350 and 500 nm. The fluorescence intensity ratio I373/I384 
was used to indicate CMC (fig. S4).
Staphylococcal culturing and harvesting
Green fluorescent protein (GFP) expression in S. aureus ATCC12600 
(American Type Culture Collection, USA) pMV148 GFP was 
generated, as described before (55). S. aureus ATCC12600GFP was 
grown, as described before (40). Briefly, the strain was cultured 
from a frozen stock onto tryptone soy agar plates [tryptone soya 
broth (TSB); Oxoid, Basingstoke, UK] supplemented with tetracycline 
(10 g ml−1) at 37°C in ambient air. For experiments, one colony 
was transferred to inoculate 10 ml of TSB, also supplemented with 
tetracycline (10 g ml−1) at 37°C for 24 hours in ambient air. This 
preculture was diluted 1:20 in 100 ml of TSB and grown statically 
for 16 hours at 37°C. Cultures were harvested by centrifugation for 
5 min at 5000g at 10°C, washed twice in PBS, sonicated for 3 × 10 s 
(Vibra-Cell model 375; Sonics and Materials Inc., Danbury, CT) 
while cooling in an ice/water bath to break bacterial aggregates, and 
lastly suspended in 10 ml of PBS to a concentration of 3 × 108 bac-
teria ml−1, as determined in a Bürker-Türk counting chamber.
Interaction of micelles with planktonic staphylococci
To demonstrate the interaction of the micelles with planktonic 
staphylococci, red fluorescent Nile red was entrapped inside the 
micelle core, as described before (40). Briefly, Nile red was dis-
solved in dimethylformamide (500 l, 1 mg ml−1) and added drop-
wise to the polymer solution from which micelles were prepared, 
as described above. This procedure yielded Nile red–loaded 
micelles.
Nile red–loaded SSPM or ZW-MSPM suspensions (500 g ml−1) 
were mixed with 1 ml of a S. aureus ATCC12600GFP (3 × 108 bacteria 
ml−1) suspended in PBS at pH 7.4 or 5.0 in a sterile 20-mm glass- 
bottom confocal dish. After 90 min at 37°C, the PBS was removed, 
and wells were washed twice with PBS. Micrographs were taken 
with confocal laser scanning microscopy (CLSM; TCS SP8, Leica, 
Wetzlar, Germany). Each assay was carried out in triplicate with 
separate bacterial cultures. All data were acquired and analyzed us-
ing Leica software version 2.0 and ImageJ software.
Penetration and accumulation of micelles in  
staphylococcal biofilms
To investigate the penetration and accumulation of micelles 
in staphylococcal biofilms, 1 ml of a staphylococcal suspension 
(3  ×  108 bacteria ml−1) was placed in a sterile 20-mm, confocal, 
glass-bottom dish for 1.5 hours at 37°C to allow bacteria to adhere. 
Next, dishes were carefully washed three times in buffer to remove 
planktonic bacteria. Then, TSB medium was added into the dishes 
and incubated at 37°C, refreshing medium every 24 hours to allow 
biofilm growth. After 48 hours, the biofilms were rinsed three 
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Nile red–loaded ZW-MSPMs suspended in PBS at pH 7.4 or 5.0 
(200 g ml−1). After 0.5 hours, exposed biofilms were rinsed three 
times with buffer and observed using CLSM to visualize penetra-
tion and accumulation of red fluorescent micelles into green fluo-
rescent biofilm. Each experiment was carried out in triplicate with 
separately grown biofilms. All data were acquired and analyzed 
using Leica software version 2.0 and ImageJ software to yield bio-
film thickness before and after exposure to micelles and micelle 
penetration and accumulation.
Bacteria and EPS in staphylococcal biofilms before and after 
exposure to micelle suspensions
To distinguish between green fluorescent staphylococci and EPS in 
biofilms, separately grown biofilms were exposed to SSPMs or ZW-
MSPMs suspended in PBS at pH 5.0 (200 g ml−1) for 120 min in 
the absence of Nile red loading and stained with tetramethyl-
rhodamine conjugate of concanavalin A, yielding red fluorescence 
of the EPS matrix. CLSM analysis, as described above, comple-
mented with COMSTAT 2 analyses allowed computer-assisted dis-
tinction between bacteria and EPS in the staphylococcal biofilms.
Determination of staphylococcal biofilm dispersal by 
micelle suspensions
To determine the biofilm mass before and after exposure to SSPMs 
or ZW-MSPMs suspended in PBS at pH 5.0 (200 g ml−1) for 120 min, 
subsequently, 500 l of a CV solution (1%, w/v) was added to each 
well to stain the biofilms for 20 min. Next, CV solution was removed, 
and wells were gently rinsed three times with PBS. After rinsing, 
500 l of 33% acetic acid was added to resuspend the stained 
biofilm for 15 min and absorbance in each well was read on a mi-
croplate reader (Spark, Tecan, Switzerland) at 595 nm. Each assay 
was carried out in triplicate with separately grown biofilms.
For scanning electron microscopy (SEM) analysis, biofilms 
were cultured on glass slides in 24-well plates, as described above. 
After exposure to PBS or suspensions (200 g ml−1) of SSPMs or 
ZW-MSPMs for 120 min, the biofilms were washed three times 
with PBS and then fixed with 2.5% glutaraldehyde for 2 hours at 
4°C. After fixation, samples were dehydrated with a series of ethanol 
solution. Last, the samples were disposed by metal spraying and 
observed using Quanta 200 SEM (FEI, Hillsboro, OR, USA).
Planktonic growth of S. aureus in the presence of micelles
To determine the effect of SSPMs and ZW-MSPMs on staphy-
lococcal growth, 100 l of a bacterial culture [optical density at 
600 nm (OD600) = 0.1] was added into 96-well plates. Optical den-
sities of the bacterial suspensions were measured using a UV-1800 
ultraviolet-visible spectrophotometer (Shimadzu, Tokyo, Japan). 
Then, staphylococci were mixed with an equal volume of a micelle 
suspension in TSB and incubated at 37°C. Growth of planktonic 
staphylococci in each well was assessed by determining the OD600 
using a microplate reader at different micelle concentrations in 
suspension (fig. S6). Each assay was carried out in triplicate with 
separate bacterial cultures.
Interaction of EPS components with ZW-MSPMs
To explore interaction of ZW-MSPMs with eDNA and proteins as 
the two major components in staphylococcal EPS, herring sperm 
DNA and proteinaceous amyloid fibrils were used to simulate the 
respective EPS components. To investigate the interaction between 
ZW-MSPMs and DNA, 2 g of ethidium bromide (EB) was dis-
solved in PBS (1 ml; pH 7.4 or 5.0). The fluorescence of the solution 
was measured at an excitation wavelength of 212 nm and emission 
at 590 nm using a spectrometer. Then, 10 g of DNA was added 
into the EB solution to bind to the DNA, and subsequently, fluores-
cence was recorded after 30 min. Suspensions of SSPMs or ZW-
MSPMs in PBS (200 g ml−1) were added into the EB-DNA solution 
to obtain series with different micelle/DNA ratios. Suspensions 
were mixed to allow micelles to disrupt EB-DNA complexes, and 
fluorescence was measured. Upon interaction between micelles 
and DNA, EB is displaced, causing a fluorescence reduction. DNA 
interaction with micelles was subsequently expressed as relative 
fluorescence calculated as
  DNA interaction =  ( 1 −  
I −  I EB  ─  I EB/DNA −  I EB 
 ) × 100% (1)
in which I is the fluorescence intensity of the EB-DNA solution 
mixed with micelles, IEB is the fluorescence intensity of EB solu-
tion, and IEB/DNA is the fluorescence intensity of the DNA and EB 
solution. Accordingly, full displacement of EB, i.e., maximal inter-
action of micelles with DNA, corresponds with 100%. Each assay 
was carried out in triplicate.
To investigate the interaction between proteins and ZW-MSPMS, 
a thioflavin T (ThT) amyloid fibril assay was performed. Five hundred 
microliters of ThT (26 M) was added to a well after biofilm growth 
and exposure to micelles for 120 min. Subsequently, ThT was re-
moved and 1 ml of PBS was added and pipetted vigorously in each 
well to detach the remaining biofilms and to homogenize the samples. 
Fluorescence in each well was measured using an excitation wave-
length of 440 nm and emission at 485 nm on a microplate reader. 
Micelle interaction with amyloidosis proteins was calculated as
  Amyloid interaction (%) =   I 0 − I ─ I 0 
  × 100% (2)
in which I0 is the ThT fluorescence of biofilm before micelle expo-
sure and I is the ThT fluorescence of biofilm after micelle exposure. 
Accordingly, maximal interaction of amyloidosis proteins was 
100%. Each assay was carried out in triplicate.
Penetration and accumulation of ciprofloxacin 
in staphylococcal biofilms after pre-exposure to  
ZW-MSPMs in vitro
To investigate the penetration of antibiotics in staphylococcal biofilms 
in vitro after pre-exposure to PBS, SSPMs, or ZW-MSPMs suspended 
in PBS at pH 5.0 (200 g ml−1) for 120 min, biofilms were subse-
quently exposed to red fluorescent cyanine 5 (CY5)–conjugated 
ciprofloxacin (40 g ml−1) for 30 min and observed using CLSM to 
visualize penetration of red fluorescent antibiotics into green fluores-
cent biofilm. All data were acquired and analyzed using Leica software 
version 2.0 and ImageJ software. Penetration of CY5-conjugated 
antibiotics was calculated relative to the highest red fluorescence 
pixel intensity in an image. Each assay was carried out in triplicate.
Antibiotic killing of staphylococci in their biofilm  
mode of growth after pre-exposure to ZW-MSPM 
suspensions in vitro
Biofilms were cultured in 24-well plates, as described above. After 
pre-exposure to TSB, SSPMs, or ZW-MSPMs suspended in TSB 
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PBS and exposed to various concentrations of ciprofloxacin for 
5 hours. The viability of the bacteria was assessed from the fluores-
cence intensity of S. aureus ATCC12600GFP biofilms on a micro-
plate reader. Fluorescence intensity immediately after ciprofloxacin 
exposure was set to 100%. In addition, after pre-exposure followed 
by exposure to ciprofloxacin at a concentration of 40 g ml−1 for 
5 hours, biofilms were scraped off a well and staphylococci was sus-
pended in PBS (pH 7.4). The suspensions were serially diluted with 
PBS, and 50 l of each dilution was plated on TSB agar and incubated 
at 37°C. After 24 hours, the number of CFUs per square centimeter 
well plate was calculated as a measure of staphylococcal viability, 
assuming homogeneous distribution of bacteria across a biofilm. The 
experiments were done in triplicate with separately grown biofilms.
Implantation of an AIW in mice
Four- to five-week-old healthy female BALB/c nude mice were 
obtained from Vital River Laboratories (Beijing, China) and sub-
jected to experiments in accordance with the Guidelines for Care 
and Use of Laboratory Animals of Nankai University. Experiments 
were approved by the Animal Ethics Committee of Nankai University 
(Tianjin, China). Nude mice were used, as they are relatively 
vulnerable to bacterial infections and therefore used in many 
evaluations of new infection-control strategies (41, 56, 57). AIWs 
were implanted (42) under anesthesia. For anesthesia, an aqueous 
solution of 4 weight % chloral hydrate (8.25 ml/kg) was injected in 
the abdominal cavity of each mouse and right flanks were disinfected 
with 70% (v/v) ethanol. Chloral hydrate was used for anesthesia, as 
chloral hydrate anesthesia lasts relatively long, as required for in-
travital imaging. To avoid abdominal irritation, chloral hydrate 
was used at a low concentration, below the concentration, causing 
abdominal irritation (58, 59). Next, a lateral incision was made 
through the skin and abdominal wall, and a suture was sewed along 
the edge of the wound. A sterilized AIW (circular coverslips, 
12 mm in diameter; Thermo Scientific, Waltham, MA, USA) in a 
titanium frame was placed glass side up in the incision. The skin 
and the abdominal wall were placed in a slot, prepared in the side 
of the titanium frame. Last, sutures were then tightened to secure 
the window frame firmly in the animal. After the surgery, the mice 
were kept at 37°C until fully recovered. After full recovery, usually 
requiring 2 days, mice were anaesthetized and injected with green 
fluorescent S. aureus ATCC12600GFP (109 bacteria ml−1, 200  l) 
underneath the AIW glass (but not onto the glass) to grow a biofilm.
In vivo self-targeting of micelles to an infectious 
staphylococcal biofilm grown underneath an AIW in mice
After 48  hours of biofilm growth underneath the window, mice 
were anaesthetized and Nile red–loaded ZW-MSPM or SSPM sus-
pensions (PBS at pH 7.4; 500 g  ml−1) were injected in the tail 
(200 l), immediately after which intravital images were taken as a 
function of time up to 30 min to monitor biofilm targeting by ZW-
MSPMs. In vivo self-targeting of micelles was monitored in three 
mice.
In vivo eradication of a staphylococcal infection underneath 
an AIW in mice by micelles in combination 
with ciprofloxacin
To monitor the biofilm eradication in vivo, mice were first injected 
in the tail with 200 l of PBS (pH 7.4) or a suspension of SSPMs and 
ZW-MSPMs (PBS at pH 7.4; 200 g ml−1), immediately followed 
by 200 l of ciprofloxacin in PBS (1 mg ml−1). The consecutive 
injection scheme was repeated daily until the end of the experi-
mental period, and intravital images were acquired each day after 
injection.
Intra-abdominal imaging in living mice
For intra-abdominal imaging, mice were anesthetized and placed 
on a custom-designed stage of a two-photon laser scanning confocal 
microscope (Olympus Corporation, Tokyo, Japan; FV1200 MPE), 
with the window frame fixed in a clamp to ensure proper focusing 
over time. After intra-abdominal imaging, images were analyzed 
using ImageJ software. Each three-dimensional (3D) image stack 
was processed using Fiji’s 3D viewer plugin (60).
Tissue analyses
The mice were sacrificed 5 days after initiating treatment. After 
sacrifice, the AIW was removed and the wound tissues were col-
lected and placed in sterile PBS. Tissue samples of each mouse were 
complemented with scrapings from the AIW that may have con-
tained adhering biofilm, homogenized, serially diluted, and plated 
on TSB agar plates, and after 18 hours of incubation at 37°C, the 
CFUs were counted. Blood samples were collected from eyes for 
routine analyses, while major organs including the heart, lung, liver, 
spleen, and kidney were removed, followed by hematoxylin and 
eosin staining and microscopic examination.
Statistical analysis
All data are expressed as means ± SD. Differences between groups 
were examined for statistical significance using a two-tailed Student’s 
t test.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/33/eabb1112/DC1
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